Results

Total Results: 2,111 records

Showing results for "risk".

361. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - asked in a study, as excluding prevalent users might omit long-term users (which could overlook risks … of death among the patients treated with aprotinin (estimates ranged from a relative risk of 1.32 … Sensitivity Analysis [propensity score] to a relative risk of 1.64 [traditional regression analysis … quickly calcification progresses once the process has begun.20 First, a model is developed for the relative … 11.2 plots the combination of the odds ratio between the exposure and the confounder (OREC) and the relative

362. Evidence Summary for Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-evidence-summary.pdf
     December 01, 2020 - • Opioids are probably associated with increased risk of short-term adverse events versus nonopioid … Evidence did not suggest an increased risk of serious harms for any intervention, though studies were … Serious adverse events were uncommon, but studies were not designed to assess risk of overdose, opioid … Being prescribed 3 opioids might be associated with increased risk of long-term use versus … Legislation mandating the use of prescription drug monitoring data and an opioid risk assessment tool

363. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
     January 17, 2014 - a number of potential adverse events associated with rosiglitazone (e.g. increased cardiovascular risks … ), pioglitazone (e.g. increased risk of bladder cancer), the combination of pioglitazone with insulin … (e.g. cardiac failure), and GLP-1 analogs or DPP-4 inhibitors (e.g. increased risk of pancreatitis)

364. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - heart failure or other cardiovascular disease use dietary supplementation and are thus placed at risk … of bias for the study as low, moderate, or high risk, and a second reviewer independently verified … Relative risk (RR) and post-treatment mean differences (MDs) were meta-analyzed using the DerSimonian … international normalized ratio; LDL-C = low-density lipoprotein-cholesterol; MD = mean difference; RR = relative … They recruited healthy subjects, or subjects with CHD or risk factors for CHD.

365. Dementia-Agitation-Aggression Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_executive.pdf
     March 01, 2016 - aggression involves at least one other person (the target of the aggression) and can represent real risks … handling of incomplete data); reporting bias (selective reporting of outcomes or analyses); and other risks … to reduce the use of antipsychotic medications in people with dementia should continue, given the risks … Evidence about the risks associated with antipsychotic use in older adults is mounting. … Development of the risk appraisal measure: a brief screen to identify risk areas and guide interventions

366. Disposition of Comments Report for Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
     June 12, 2012 - other tweaks from invasive cardiologists, but from my "doc in a box" vantage point of benefits and risks … According to the Joint Commission’s latest Sentinel Alert, the risks associated with the use of ionizing … Feinstein, Steven (International Contrast Ultrasound Society) General 1 Radiation Risks of Diagnostic … We have added more details about the radiation risk to the Safety Concerns and Risks section. … The review includes 11 studies reporting safety concerns and risks, including three studies that show

367. March 2nd Mitigating Racial Bias in Healthcare Algorithms Public Meeting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-2.pdf
     May 15, 2023 - algorithm scoreRe al iz ed h ea lth (a ct iv e ch ro ni c co nd iti on s) Algorithm risk … total health costs well for Black and White patients Re al iz ed c os t ( TM E) Algorithm risk … Risk of bias (ROB) The likelihood that a study’s reported results are misleading due to methodologic … Care Management 1 [Obermeyer 2019] Commercial risk prediction calculator None N Eligibility for … Index KQ 2 Shores 201386 Modellingd * *  Cardiovascular risk ASCVDc KQ 2 Weale 202173 Modellingd

368. S116 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - This model yielded adjusted estimates of risk differences. … using more hazardous treatments, the bias would be conservative, tending to narrow the differ- ence in risks … †Prevalence of risk factor among atypical users minus prevalence of risk factor among conventional users … Risk of death in elderly users of conventional vs. atypical antipsychotic medications. … Benzodiazepines of long and short elimination half-life and the risk of hip fracture.

369. Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
     January 31, 2023 - Can risks/benefits be used instead? … Risk/benefit terminology may imply that we did some sort of risk benefit analysis. … The findings were generated from subgroup analyses and suffer higher risk of bias. … of recurrence (with all the caveats of risk & benefit & patient preference discussed). … agree with the AHRQ review that there is currently insufficient data to draw conclusions about the risks

370. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
     March 22, 2023 - assess risk of bias of included studies. … Each study will be dual reviewed for risk of bias by two team members. … points on a 0 to 100-point scale • SMD >0.8 • RR/OR ≥2.0 MD = mean difference; OR = odds ratio; RR = relative … The social ecology of community and neighborhood and risk for antisocial behavior. … Assessing the Risk of Bias in Systematic Reviews of Health Care Interventions.

371. Methods Guide for Medical Test Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-bias_methods.pdf
     July 01, 2012 - Methods Guide for Medical Test Reviews 5-1 Chapter 5 Assessing Risk of Bias as a Domain of Quality … Risk: Low/High/Unclear *Questions related to assessing applicability were excluded here. … Summarizing risk of bias based on several outcomes within a study is not recommended. … Systematic review: family history in risk assessment for common diseases. … Assessing risk of bias as a domain of quality in medical test studies.

372. Hip-Fracture-Pain Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_consumer.pdf
     May 01, 2011 - People with broken hips may be at risk for other problems, such as pneumonia, blood clots, and muscle … There is very little known about the benefits and risks of traction, acupressure, muscle-relaxation … We do not know if using both traction and medicines for pain increases your risks of serious side effects … What are the risks of acupressure, muscle-relaxation therapy, and TENS? … There is not enough research to say if these options have any risks or can cause any side effects

373. Research Protocol: Clostridium difficile Infection Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
     December 23, 2014 - Assessment of Methodological Risk of Bias of Individual Studies Risk of bias of eligible studies will … across risk of bias approaches. … If the risk of bias assessment tool is similar to our approach, we will separately assess risk of bias … We will calculate risk ratios (RR) and absolute risk differences (RD) with the corresponding 95 percent … Chapter 8: Assessing risk of bias in included studies.

374. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - Thirteen comparative studies reported risks. … Thus, ES-2 there was insufficient evidence regarding the comparative risks of various NIT modalities … Thirteen comparative studies reported risks. … Thus, there was insufficient evidence regarding the comparative risks of various NIT modalities in … ), the extant literature does not provide sufficient evidence to conclude whether safety concerns, risks

375. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - information tool for use by consumers/patients Addresses treatment of a defined condition Addresses risks … Information Products from Other Countries How is risk and benefit communicated to health care consumers … Understanding NICE guidance—information for people who have or are at increased risk of cardiovascular … Strength of Evidence Yes Yes, OTC meds, NSAIDs, COX-2s, Topicals, Supple-ments Yes, pain relief and risk … of CV event or GI bleeding Yes, sort out benefit, risk, cost of choices Narrative, Q&A, Price comparisonchart

376. Prostate-Cancer-Therapies-Update Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_consumer.pdf
     January 01, 2016 - � Men aged 50 years or older have a higher risk of prostate cancer. … � The risk of prostate cancer is higher for men with a history of prostate cancer in their family. … Your risk level can help you and your doctor decide what treatment may be best for you. … Risk Level* PSA Level Gleason Score T-Score Low risk† 10 or less 6 or less T1–T2a Medium risk†† 10 … These may include your risk level, your age, and any other health problems.

377. Alcohol-misuse-drug-therapy-140326 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
     January 27, 2012 - for whom acamprosate and oral naltrexone are not suitable, or prefer disulfiram and understand the relative … risks of taking the drug; and (3) to have specialist and competent staff administer pharmacological … Assessment of Methodological Risk of Bias of Individual Studies—To assess the risk of bias (i.e., internal … A study assessed as high risk of bias has significant risk of bias (e.g., stemming from serious issues … For binary outcomes (e.g., adverse events), we will calculate risk differences between groups or risk

378. Core-Needle Biopsy for Breast Abnormalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_clinician.pdf
     May 01, 2016 - to 0.94) ��� Table 2: Comparative Effectiveness of Core-Needle Biopsy Methods in Women at Average Risk … Open surgical biopsy samples most or all of the lesion, so it is considered to have a smaller risk of … However, open procedures may carry a greater risk of complications, such as bleeding or infection, when … Studies on the accuracy of core-needle breast biopsies were deemed to have moderate to high risk of … The applicability of findings to women at high risk of breast cancer is uncertain because few studies

379. Topic 0549 Diagnosis and Management of Gout NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0648-140819.pdf
     June 24, 2014 - Staff-Generated PICO Population(s): Adults with or at risk of having gout Intervention(s): Clinical … Does the risk of adverse effects differ according to patient baseline diet and fluid intake? c. … Does the risk of adverse effects differ according to joint vs. systemic involvement in gout? … In adults with a history of gout, what is the evidence that pharmacological therapies to reduce risk … Does the risk of adverse effects differ according to patient baseline diet and fluid intake? c.

380. Disposition of Comments for CER 166 Calcineurin Inhibitors (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
     March 15, 2016 - comparing the immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity risks … be interesting to know if it is possible to identify at what point in the withdrawal process the risks … It is not clear where the benefits of minimization end and the risks of withdrawal begin. … By indirectly endorsing this perspective, this review risks exacerbating a trend toward overzealous … However, risks and benefits will vary greatly depending on what type of donor organ is being used,